Previous Close | 39.50 |
Open | 39.81 |
Bid | 45.75 |
Ask | 50.20 |
Strike | 40.00 |
Expire Date | 2026-01-16 |
Day's Range | 39.50 - 39.81 |
Contract Range | N/A |
Volume | |
Open Interest | 21 |
FDA approves Sanofi's Dupixent for COPD. Eli Lilly is set to invest $4.5 billion to build a new manufacturing and research site in Indiana.
ABBV lowers adjusted earnings guidance for 2024 from $10.71-$10.91 per share to $10.67-$10.87 to account for acquisition costs.
Multi-asset funds have been put forward as one way to manage the impact of a mooted capital gains tax hike on investment portfolios.